Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or above- and below-the-knee. Pharos Excimer Laser is a powerful 308 nm ultraviolet-B excimer laser used by physicians as a tool to treat chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma. Ra Medical Systems, Inc. is based in Carlsbad, California.
| Revenue (Most Recent Fiscal Year) | $7.20M |
| Net Income (Most Recent Fiscal Year) | $-56.96M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.35 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.36 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -807.13% |
| Net Margin (Trailing 12 Months) | -807.30% |
| Return on Equity (Trailing 12 Months) | -140.19% |
| Return on Assets (Trailing 12 Months) | -102.78% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.07 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.74 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.08 |
| Inventory Turnover (Trailing 12 Months) | 2.56 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.47 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.43 |
| Earnings per Share (Most Recent Fiscal Year) | $-4.33 |
| Diluted Earnings per Share (Trailing 12 Months) | $-3.01 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 72.47M |
| Free Float | 70.73M |
| Market Capitalization | $18.65M |
| Average Volume (Last 20 Days) | 3.59M |
| Beta (Past 60 Months) | 1.17 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 5.12% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |